Background: Small, unrandomized studies have indicated that pharmacologically induced blood pressure elevation may improve function in ischemic stroke, presumably by improving blood flow to ischemic, but noninfarcted tissue (which may be indicated by diffusion-perfusion mismatch on MRI). We conducted a pilot, randomized trial to evaluate effects of pharmacologically induced blood pressure elevation on function and perfusion in acute stroke. Methods: Consecutive series of patients with large diffusion-perfusion mismatch were randomly assigned to induced blood pressure elevation (‘treated’ patients, n = 9) or conventional management (‘untreated’ patients, n = 6). Results: There were no significant differences between groups at baseline. NIH Stroke Scale (NIHSS) scores were lower (better) in treated versus untreated patients at day 3 (mean 5.6 vs. 12.3; p = 0.01) and week 6–8 (mean 2.8 vs. 9.7; p < 0.04). Treated (but not untreated) patients showed significant improvement from day 1 to day 3 in NIHSS score (from mean 10.2 to 5.6; p < 0.002), cognitive score (from mean 58.7 to 27.9% errors; p < 0.002), and volume of hypoperfused tissue (mean 132 to 58 ml; p < 0.02). High Pearson correlations between the mean arterial pressure (MAP) and accuracy on daily cognitive tests indicated that functional changes were due to changes in MAP. Conclusion: Results warrant a full-scale, double-blind clinical trial to evaluate the efficacy and risk of induced blood pressure elevation in selective patients with acute/subacute stroke.

Keywords:
Cerebrovascular disease/stroke, Aphasia, Hemispatial neglect
1.
Mayberg MR, Batjer HH, Dacey R, et al: Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 1994;90:2592–2605.
2.
Drummond JC, Oh YS, Cole DJ, Shapiro HM: Phenylephrine-induced hypertension reduces ischemia following middle cerebral artery occlusion in rats. Stroke 1989;20:1534–1538.
3.
Hosomi N, Tsuda Y, Ichihara SI, Kitadai M, Ohyama H, Matsuo H: Duration threshold of induced hypertension on cerebral blood flow, energy metabolism, and edema after transient forebrain ischemia in gerbils. J Cereb Blood Flow Metab 1996;16:1224–1229.
4.
Hayashi S, Nehls DG, Kieck CF, Vielma J, DeGirolami U, Crowell RM: Beneficial effects on induced hypertension on experimental stroke in awake monkeys. J Neurosurg 1985;60:151–157.
5.
Wise G, Sutter R, Burkholder J: The treatment of brain ischemia with vasopressor drugs. Stroke 1972;3:135–140.
6.
Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz W: Pharmacological elevation of blood pressure in acute stroke. Stroke 1997;28:2133–2138.
7.
Rordorf G, Koroshetz W., Ezzeddine MA, Segal AZ, Buonanno FS: A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 2001;56:1210–1213.
8.
Astrup J, Symon L, Branston NM, Lassen NA: Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977;8:51–57.
9.
Skyhøj Olsen T, Bruhn P, Oberg RG: Cortical hypoperfusion as a possible cause of ‘subcortical aphasia’. Brain 1986;106:393–410.
10.
Skyhøj Olsen T, Larsen B, Herning M, Skriver EB, Lassen N: Blood flow and vascular reactivity in collaterally perfused brain tissue. Stroke 1983;14:332–401.
11.
Powers WJ: Acute hypertension after stroke: The scientific basis for treatment decisions (editorial). Neurology 1993;43:461–467.
12.
Baron JC, Marchal G: Functional imaging in vascular disorders; in Mazziotta JC, Toga AW, Frackowiak RSJ (eds): Brain Mapping: The Disorders. San Diego, Academic Press, 2000, pp 299–311.
13.
Barber PA, Darby DG, Desmond PM, et al: Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418–426.
14.
Beauchamp N, Bryan RN: Acute cerebral ischemic infarction: A pathophysiologic review and radiologic perspective. AJR Am J Roentgenol 1998;171:73–84.
15.
Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP: Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome. Ann Neurol 1999;46:568–578.
16.
Neumann-Haefelin T, Wittsack H, Wenserski F, et al: Diffusion and perfusion-weighted MRI: The DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591–1597.
17.
Hillis AE, Wityk RJ, Tuffiash E, Beauchamp NJ, Jacobs MA, Barker PB, Selnes OA: Hypoperfusion of Wernicke’s area predicts severity of semantic deficit in acute stroke. Ann Neurol 2001;50:561–566.
18.
Warach S, Gaa J, Siewart B, Wielopolski P, Edelman RR: Acute human stroke studied by whole brain echo planar diffusion-weighted MRI. Ann Neurol 1995;37:232–241.
19.
Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Mosely ME: Clinical utility of diffusion-weighted magnetic imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574–580.
20.
Baird AE, Benfield A, Schlaug G, et al: Enlargement of human cerebral ischemia measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;41:581–589.
21.
Sorensen AG, Buonanno FS, Gonzalez RG, et al: Hyperacute stroke: Evaluation with combined multisection diffusion-weighted imaging and hemodynamically-weighted echo-planar MR imaging. Radiology 1996;199:391–401.
22.
Hillis AE, Barker PB, Beauchamp NJ, Winters BD, Mirski M, Wityk RJ: Restoring blood pressure reperfused Wernicke’s area and improved language. Neurology 2001;56:670–672.
23.
Hillis AE, Barker PB, Beauchamp NJ, Gordon B, Wityk RJ: MR perfusion imaging reveals regions of hypoperfusion associated with aphasia and neglect. Neurology 2000;55:782–788.
24.
Fink JN, Selim MH, Kumar S, et al: Is the association of National Institutes of Health Stroke Scale Scores and acute magnetic resonance imaging stroke volume equal for patients with right- and left-hemisphere stroke? Stroke 2002;33:954–958.
25.
Bevan JA, Duckworth J, Laher I, Oriowo MA, McPherson GA, Bevan RD: Sympathetic control of cerebral arteries: Specialization in receptor type, reserve, affinity, and distribution. FASEB J 1987;1:193–198.
26.
Wityk RJ, Pessin MS, Kaplan RF, Caplan LR: Serial assessment of acute stroke using the NIH stroke scale. Stroke 1994;25:362–365.
27.
Saxena R, Wijnhoud A, Koudstaal PJ, van den Meiracker AH: Induced elevation of blood pressure in the acute phase of ischemic stroke in humans. Stroke 2000;31:546–548.
28.
Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG: Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315–1320.
29.
Goodglass H, Wingfield A: Word-finding deficits in aphasia: Brain-behavior relations and symptomatology; in Goodglass H (ed): Anomia. London, Academic Press, 1997, pp 5–30.
30.
Hart J, Gordon B: Delineation of single-word semantic comprehension deficits in aphasia, with anatomical correlation. Ann Neurol 1990;27:226–231.
31.
Lesser R, Luders H, Morris HH, et al: Electrical stimulation of Wernicke’s area interferes with comprehension. Neurology 1986;36:658–663.
32.
Wise R, Chollet F, Hadar U, Friston K, Hoffner E, Frackowiak R: Distribution of cortical neural networks involved in word comprehension and word retrieval. Brain 1991;114:1803–1817.
33.
Whatmough C, Chertkow H: Neuroanatomical aspects of naming; in Hillis AE (ed): Handbook of Language Disorders. Philadelphia, Psychology Press, in press.
34.
Obrien MD, Jordan MM, Waltz AG: Ischemic cerebral edema and the blood-brain barrier. Arch Neurol 1974;30:461–465.
35.
Hatashita S, Hoff J, Ishii S: Focal brain edema associated with acute arterial hypertension. J Neurosurg 1986;64:643–649.
36.
Chamorro A, Vila N, Ascaso C, Elices E, Schonwille W, Blanc R: Blood pressure and functional recovery in acute ischemic stroke. Stroke 1998;29:1850–1853.
37.
Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.